A. Shenton

发表

Bayesian evaluation of breast cancer screening using data from two studies

L. Tabár, S. Duffy, A. Howell, 2003, Statistics in medicine.

A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype–phenotype correlations

D. Evans, A. Shenton, E. Majounie, 2011, Journal of Medical Genetics.

Mosaicism in neurofibromatosis type 2: an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification

D. Evans, S. Huson, R. Ramsden, 2007, Journal of Medical Genetics.

Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening

D. Evans, S. Huson, A. Shenton, 2007, Journal of Medical Genetics.

BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives.

Andrew Shenton, Sheila Seal, Anthony Howell, 2006, European journal of cancer.

Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations

D. Evans, A. Shenton, F. Lalloo, 2008, Clinical genetics.

Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations

D. Evans, A. Shenton, F. Lalloo, 2009, Clinical genetics.

Adult weight gain and central obesity in women with and without a family history of breast cancer: a case control study

A. Howell, A. Shenton, R. Swindell, 2007, Familial Cancer.

Uptake of Risk-Reducing Surgery in Unaffected Women at High Risk of Breast and Ovarian Cancer Is Risk, Age, and Time Dependent

A. Howell, D. Evans, A. Shenton, 2009, Cancer Epidemiology, Biomarkers & Prevention.

The Screening of Women Aged Less Than 50 Years At Increased Risk of Breast Cancer By Virtue of Their Family History.

S. Duffy, A. Howell, C. Boggis, 2006 .

Clinical follow‐up after bilateral risk reducing (‘prophylactic’) mastectomy: mental health and body image outcomes

A. Howell, A. Shenton, F. Lalloo, 2000, Psycho-oncology.

Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers

P. Møller, D. Evans, C. V. van Asperen, 2008, Journal of Medical Genetics.

Uptake of screening and prevention in women at very high risk of breast cancer

A. Howell, C. Boggis, A. Shenton, 2001, The Lancet.

BRCA1/2 predictive testing: a study of uptake in two centres

R. Eeles, A. Ardern-Jones, D. Craufurd, 2004, European Journal of Human Genetics.

Risk perception and cancer worry: an exploratory study of the impact of genetic risk counselling in women with a family history of breast cancer

A. Howell, D. Evans, A. Shenton, 2001, Journal of medical genetics.

Comparison of proactive and usual approaches to offering predictive testing for BRCA1/2 mutations in unaffected relatives

D. Craufurd, D. Evans, A. Shenton, 2009, Clinical genetics.

Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system.

D. Eccles, D. Evans, M. Porteous, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Non-random transmission of mutant alleles to female offspring in BRCA carriers

D. Evans, A. Shenton, S. Sharif, 2005, Journal of Medical Genetics.

Risk-reducing surgery for ovarian cancer: outcomes in 300 surgeries suggest a low peritoneal primary risk

D. Evans, A. Shenton, F. Lalloo, 2009, European Journal of Human Genetics.

What are the implications in individuals with unilateral vestibular schwannoma and other neurogenic tumors?

D. Evans, S. Huson, R. Ramsden, 2008, Journal of neurosurgery.

Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: Risks of breast/ovarian cancer quoted should reflect the cancer burden in the family

A. Howell, D. Evans, A. Shenton, 2008, BMC Cancer.

Screening by mammography, women with a family history of breast cancer.

A. Howell, D. Evans, A. Threlfall, 1998, European journal of cancer.

Empirical development of improved diagnostic criteria for neurofibromatosis 2

D. Evans, R. Ramsden, A. Shenton, 2011, Genetics in Medicine.

A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO

N. Rahman, A. Howell, D. Eccles, 2004, Journal of Medical Genetics.

Basal Cell Carcinomas in Gorlin Syndrome: A Review of 202 Patients

Andrew Shenton, Mohammed Imran Sajid, D. Evans, 2010, Journal of skin cancer.

Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening

D. Evans, A. Shenton, F. Lalloo, 2006, Journal of Medical Genetics.

Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics

R. Eeles, D. Easton, P. Pharoah, 2008, Journal of Medical Genetics.

Inherited association of breast and colorectal cancer: limited role of CHEK2 compared with high‐penetrance genes

A. Shenton, F. Lalloo, D. Speake, 2006, Clinical genetics.

Probability of BRCA1/2 mutation varies with ovarian histology: results from screening 442 ovarian cancer families

A. Shenton, F. Lalloo, A. Wallace, 2008, Clinical genetics.

Risk reducing mastectomy: outcomes in 10 European centres

A. Howell, P. Møller, D. Eccles, 2008, Journal of Medical Genetics.

Further genotype – phenotype correlations in neurofibromatosis 2

A. Shenton, R. Ferner, R. Ramsden, 2009, Clinical genetics.

Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers

D. Easton, A. Antoniou, D. Evans, 2006, Breast Cancer Research.

Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme

A Howell, A. Howell, D. Evans, 2003, Journal of medical genetics.

Impaired Tamoxifen Metabolism Reduces Survival in Familial Breast Cancer Patients

D. Evans, W. Newman, S. Roberts, 2008, Clinical Cancer Research.

Screening younger women with a family history of breast cancer--does early detection improve outcome?

D. Evans, C. Boggis, A. Shenton, 2006, European journal of cancer.

Breast cancer susceptibility variants alter risks in familial disease

A. Howell, D. Evans, W. Newman, 2009, Journal of Medical Genetics.

Better Life Expectancy in Women with BRCA2 Compared with BRCA1 Mutations Is Attributable to Lower Frequency and Later Onset of Ovarian Cancer

A. Howell, G. Jayson, A. Shenton, 2008, Cancer Epidemiology Biomarkers & Prevention.

Initial results of a study into the effectiveness of breast cancer screening in a population identified to be at high risk.

S. Duffy, J. Myles, R. Nixon, 2001, Revue d'epidemiologie et de sante publique.

Impaired Tamoxifen Metabolism Reduces Survival in Familial Breast Cancer Patients

A. Shenton, F. Lalloo, S. Howell, 2008, Clinical Cancer Research.